News | News By Subject | News by Disease News By Date | Search News

Infection/Antibiotics News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Warp Drive Bio Hands Over Antibiotics Program to Sanofi (SNY)     11/30/2016
Tiny Dipexium (DPRX) Craters After Lead Drug Locilex Flunks Phase III Trials     10/25/2016
A Closer Look at the Pipelines Pfizer (PFE) Inherited From Recent Acquisitions     10/5/2016
Basilea (BSLN.SW) Ends Further Development of Inhaled Antibiotic BAL30072     8/15/2016
Seres Therapeutics (MCRB) Craters in Phase II ECOSPOR Study; CEO and Execs Profit on Insider Sales     7/29/2016
Gilead (GILD)'s Odefsey Successful in Two Phase IIIb Studies     7/22/2016
Amid Trial Concerns, FDA Delays Approval Decision for Merck & Co. (MRK)'s C. Diff Drug, New PDUFA Date Set     7/22/2016
FDA Spurns Novartis AG (NVS)'s Copy of Amgen (AMGN) Blockbuster Neulasta     7/19/2016
FDA Advisors Backs Approval for Merck & Co. (MRK)'s Infectious Diarrhea Drug     6/10/2016
FDA Questions Merck & Co. (MRK)'s C. Diff Diarrhea Medication’s Efficacy     6/8/2016
FDA Warns Against Off-Label Use of Johnson & Johnson (JNJ)'s Nizoral Tablets to Treat Skin And Nail Infections, Linked to Patient Death     5/20/2016
TetraPhase (TTPH) Drops After the FDA Requests More Data for Eravacycline NDA Submission     5/13/2016
More Bad News for Chimerix (CMRX) as Brincidofovir Fails Another Late Stage Study     5/9/2016
Basilea (BSLN.SW) Wins $100 Million Contract to Fund Phase III Ceftobiprole Program     4/20/2016
Booming Seres Therapeutics Looks to Move Lead Product into Phase III, Expand in Cambridge     4/14/2016

News from Around the Web
Woman Dies Of A Superbug Resistant To Every Antibiotic In The U.S., CDC Study     1/13/2017
From Click Chemistry To Antibiotic Spider Silk, University of Nottingham Study     1/9/2017
Portable Antibiotic Resistance Detector Developed, UCLA Study     12/27/2016
New Tool May Help Combat Antibiotic Resistance, University of Sheffield Study     11/1/2016
Scientists Are Freaking Out Over This 25-Year-Old's Solution To Superbugs, University Of Montreal Study     9/28/2016
Inside The 10-Year, $1 Billion Battle For The Next Critical Antibiotic     9/21/2016
Saving Antibiotics So That Antibiotics Can Save Lives     9/16/2016
Kids With Exposure To Antibiotics Linked To Allergies Later In Life, Utrecht University Study     9/6/2016
Rapid Bacterial Infection Test Reduces Antibiotic Use, University of Oxford Study     8/3/2016
A Potential Lifesaver Lies Unrecognized In The Human Body, University of Tubingen Study     7/28/2016
Infections, Antibiotic Use Linked To Manic Episodes In People With Serious Mental Illness, Johns Hopkins University School of Medicine Study     7/21/2016
Can An Antibiotic Help You? Quick Test Might Tell, Quinnipiac University's School Of Medicine Study     7/8/2016
Big Pharma Drawn Back To Antibiotics     7/5/2016
Travelers Could Gain Antibiotic Resistant Genes In Just Two Days, Maastricht University Study     6/28/2016
There's A 30% Chance You Don't Need That Antibiotic     5/6/2016

Press Releases
Washington University School of Medicine Release: Persistent Infection Keeps Immune Memory Sharp, Leading To Long-Term Protection     1/17/2017
RondinX Release: Company Debuts To Accelerate Drug Development With A Breakthrough Microbiome Computational Platform     1/17/2017
Osiris (OSIR) Announces Scientific Manuscript Reporting Antimicrobial Properties Of Cryopreserved Viable Amnion Is Available Electronically In Peer-Reviewed Journal     1/16/2017
Shionogi Release: Pharma's Investigators are Prepping a FDA App for New Antibiotic After Positive Trial     1/13/2017
ViraCyte Release: Pharma Granted U.S. FDA Fast Track Designation For Viralym-C     1/10/2017
Ferring Pharma Partners With Intralytix To Develop Bacteriophage Treatments For Conditions Associated With The Microbiome And Drug-Resistant Bacteria     1/9/2017
Synthetic Biologics (SYN)' SYN-004 (Ribaxamase) Achieves Primary Endpoint In Phase 2b Trial For C. Difficile Infection (CDI)     1/5/2017
Auspherix Provides Update On Its New Class Of Organogold Antibiotics     1/5/2017
Rebiotix Treats First Patient In Phase 1 Study Of RBX7455, An Orally Delivered Broad-Spectrum Non-Frozen Microbiota Capsule For Recurrent Clostridium Difficile Infection     1/4/2017
Cardiome Pharma Corp. (COM.TO) Announces Commercial Launch Of XYDALBA (Dalbavancin) In Germany     12/20/2016
Spero Initiates First Clinical Study Of Lead Potentiator Candidate For The Treatment Of Multidrug Resistant Gram-Negative Infections     12/19/2016
Medivir (MVRBF)'s Fusion Inhibitor For The Treatment Of Respiratory Syncytial Virus Infection, MIV-323, Enters Non-Clinical Development     12/14/2016
Vyome Presents On Development Of Dual Action Rational Therapeutics (Darts) To Treat Infections Caused By Antibiotic-Resistant Skin Opportunist Pathogens At Re-Entering Antibacterial Discovery And Development Summit 2016     12/8/2016
Cardiome Pharma Corp. (COM.TO) Announces Commercial Launch Of Xydalba (Dalbavancin) In The UK     12/8/2016
Achillion (ACHN) Release: Data Presented At American Society of Hematology Meeting Demonstrate Potential Advantages Of Factor D Inhibition For The Treatment Of Complement Alternative Pathway-Mediated Diseases     12/6/2016

//-->